Evidence map›Paper›PMID 34180150›Full record

ReviewBiotechnology progress2021

Microbioreactor (micro-Matrix) potential in aerobic and anaerobic conditions with different industrially relevant microbial strains.

Sergio D'ambrosio, Michela Ventrone, Alberto Alfano, Chiara Schiraldi, Donatella Cimini

Abstract readReview
In one paragraph

Review in Biotechnology progress, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Heterologous production of chondroitin.Biotechnology reports (Amsterdam, Netherlands) · 2022
    Review
  6. Optimization of growth ofFrontiers in bioengineering and biotechnology · 2022
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sergio D'ambrosioDepartment of Experimental Medicine, Section of Biotechnology, Medical Hystology and Molecular Biology, University of Campania L. Vanvitelli, Naples, Italy.
Michela VentroneDepartment of Experimental Medicine, Section of Biotechnology, Medical Hystology and Molecular Biology, University of Campania L. Vanvitelli, Naples, Italy.
Alberto AlfanoDepartment of Experimental Medicine, Section of Biotechnology, Medical Hystology and Molecular Biology, University of Campania L. Vanvitelli, Naples, Italy.
Chiara SchiraldiDepartment of Experimental Medicine, Section of Biotechnology, Medical Hystology and Molecular Biology, University of Campania L. Vanvitelli, Naples, Italy.
Donatella CiminiDepartment of Experimental Medicine, Section of Biotechnology, Medical Hystology and Molecular Biology, University of Campania L. Vanvitelli, Naples, Italy.ORCID 0000-0002-4961-8819

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microscale fermentation systems are important high throughput tools in clone selection, and bioprocess set up and optimization, since they provide several parallel experiments in controlled conditions of pH, temperature, agitation, and gas flow rate. In this work we evaluated the performance of biotechnologically relevant strains with different respiratory requirements in the micro-Matrix microbioreactor. In particular Escherichia coli K4 requires well aerated fermentation conditions to improve its native production of chondroitin-like capsular polysaccharide, a biomedically attractive polymer. Results from batch and fed-batch experiments demonstrated high reproducibility with those obtained on 2 L reactors, although highlighting a pronounced volume loss for longer-term experiments. Basfia succiniciproducens and Actinobacillus succinogenes need CO

Indexed as

ActinobacillusAerobiosisAnaerobiosisBioreactorsEscherichia coliFermentationMicrotechnologySuccinic AcidSuccinic Acidaerobic and anaerobic fermentationsmicrobioreactormicro-Matrixoptimal growth conditionsscale down

Identifiers

PMID34180150
PMCPMC8596446

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.